CLASS II Drug recall · Reported 20 Mar 2019 · FDA Enforcement Report
Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mg recalled
Macleods Pharma Usa is recalling Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mg, distributed nationwide in the US. The recall was initiated on 25 Feb 2019 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1003-2019
- FDA event ID
- 82196
- Recalling firm
- Macleods Pharma Usa, Plainsboro, NJ
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 25 Feb 2019
- FDA classified
- 14 Mar 2019
- Reported
- 20 Mar 2019
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
- Drug class
- Blood Pressure Medication
Timeline
| 25 Feb 2019 | Recall initiated by company | |
| 14 Mar 2019 | Classified by FDA | +17 days |
| 20 Mar 2019 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mg, 30-count bottles, Rx Only, Manufactured for:Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured for: Macleods Pharmaceuticals Ltd. Baddi, Himchal Pradesh INDIA, NDC 33342-128-07
Where it was distributed
Nationwide within the United States
Questions about this recall
Is Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mg recalled?
Yes. Macleods Pharma Usa recalled Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mg on 25 Feb 2019. The recall is Class II and its status is Terminated. Recall number D-1003-2019.
Why was it recalled?
Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.
Which lots are affected?
Lot #: BTL703A, Exp. Feb-19; BTL705A, Exp Apr-19; BTL706A, BTL707A, BTL708A, Exp May-19; BTL709A, Exp Nov-19; BTL710A, BTL711A, BTL801A, Exp. Dec-19; BTL802A, BTL803A, Exp.Feb-20; BTL804A, BTL805A, Exp. Apr-20; BTL807A, BTL807B, Exp May- 20; BTL809A, BTL810A, Exp Jul-20; BTL811A, Exp Sep-20; BTL812A, BTL813A Exp Oct-20
Where was it sold?
Nationwide within the United States
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Macleods Pharma Usa
All 34| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Levothyroxine Sodium Tablets USP 150 mcg recalled by Macleods Pharma UsaLevothyroxine Sodium | Macleods Pharma Usa | Potency & Assay | Nationwide |
| Drug | CLASS II | Losartan Potassium and Hydrochlorothiazide Tablets recalledLosartan Potassium And Hydrochlorothiazide | Macleods Pharma Usa | Foreign Material | Nationwide |
| Drug | CLASS III | Levofloxacin Tablets, USP 500 mg recalled by Macleods Pharma Usa | Macleods Pharma Usa | Packaging Defects | Nationwide |
| Drug | CLASS II | Eszopiclone Tablets, USP 1 mg recalled by Macleods Pharma UsaEszopiclone | Macleods Pharma Usa | Packaging Defects | Nationwide |
| Drug | CLASS II | Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 recalledLosartan Potassium And Hydrochlorothiazide | Macleods Pharma Usa | Potency & Assay | Nationwide |
Other Telmisartan and hyrdochlorothiazide recalls
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Telmisartan and Hyrdochlorothiazide Tablets recalled | Macleods Pharma Usa | Potency & Assay | Nationwide |
| Drug | CLASS II | Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg recalled | Macleods Pharma Usa | Potency & Assay | Nationwide |